SCHEMBL6206031

SCHEMBL6206031

CC(CO)Cc1cnc(Cl)nc1Cl

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDXK O00764 1/20 0.33
ABL1 P00519 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204439 0.83
SCHEMBL13498788 0.82 P2RX3 (0.35)
SCHEMBL16580713 0.75 PDXK (0.48) PDXK
SCHEMBL6204668 0.72 PDXK (0.37) PDXK
SCHEMBL4442536 0.71 ALOX5AP (0.31)
SCHEMBL6202984 0.71 MAPT (0.42)
SCHEMBL7966254 0.71 KDM4E (0.32) PDXK
SCHEMBL4579208 0.71 NOS3 (0.36) PDXK
SCHEMBL30238970 0.71 NOS3 (0.36) PDXK
SCHEMBL17589036 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1560832-A1 PYRIMIDO 4,5-D PYRIMIDINE DERIVATIVES WITH ANTICANCER ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2005-08-10 EP disclosed
WO-2004041822-A1 PYRIMIDO[4,5-D]PYRIMIDINE DERIVATIVES WITH ANTICANCER ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2004-05-21 WO disclosed